Literature DB >> 19478535

Electron impact mass spectroscopic studies on mouse retinal fatty acids: effect of diabetes.

K R Hegde1, S D Varma.   

Abstract

AIM: The primary objective of these investigations was to determine the fatty acid composition of the mouse retina as affected by diabetes. Additionally, in order to ascertain if there is any accumulation of lipids in the diabetic retina as occurs in many diabetic tissues, its total fatty acid content was also determined.
METHODS: Lipids in the retina of normal and diabetic mice were trans-methylated with methanolic HCl. The esters so prepared were analyzed for fatty acids by gas chromatography-mass spectrometry, qualitatively as well as quantitatively.
RESULTS: The major fatty acids in the retina were palmitic (PA), oleic (OA), stearic (SA), arachidonic (AA) and docosahexaenoic (DHA) acids. The content of all these fatty acids increased significantly in the diabetic retina, reflecting lipidosis. The major increases (approximately 3 times the normal) were found in PA, OA, SA and AA. The increase in DHA, however, was much less (approximately 1.4 times). The relative percentages of fatty acids were also affected. While the relative percentages of PA and OA increased in the diabetic retina, there were insignificant changes in the percentages of SA and AA. Interestingly, the relative percentage of DHA underwent a significant decrease, about 50% of the normal.
CONCLUSIONS: The results show that there is excessive accumulation of lipids in the diabetic retina. This is consistent with the known increased mobilization of lipids from the adipose tissue and their accumulation in other tissues under diabetic conditions. On a percentage profile basis, while the relative percentage of most of the fatty acids increased, the DHA percentage significantly decreased. This could be explained by its dilution by the fatty acids coming from the fat depots which lack DHA. Physiologically, the excessive accumulation of fatty acids in the diabetic retina correlates with the lipofuscinosis and neural dysfunction associated with this disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19478535      PMCID: PMC3712809          DOI: 10.1159/000219679

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  24 in total

1.  Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy.

Authors:  R A Kowluru; J Tang; T S Kern
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

2.  Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect.

Authors:  H Y Kim; M Akbar; A Lau; L Edsall
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

3.  Diabetes-induced biochemical changes in rat lens: attenuation of cataractogenesis by pyruvate.

Authors:  W Zhao; P S Devamanoharan; M Henein; A H Ali; S D Varma
Journal:  Diabetes Obes Metab       Date:  2000-06       Impact factor: 6.577

Review 4.  Skeletal muscle lipid accumulation in obesity, insulin resistance, and type 2 diabetes.

Authors:  Bret H Goodpaster; Donna Wolf
Journal:  Pediatr Diabetes       Date:  2004-12       Impact factor: 4.866

5.  Increased lipid peroxidation in type 2 poorly controlled diabetic patients.

Authors:  E Altomare; G Vendemiale; D Chicco; V Procacci; F Cirelli
Journal:  Diabete Metab       Date:  1992 Jul-Aug

6.  Prevention of oxidative stress to the retina by pyruvate. A preliminary report.

Authors:  Kavita R Hegde; Shambhu D Varma
Journal:  Ophthalmologica       Date:  2008-05-22       Impact factor: 3.250

7.  Alterations in retinal rod outer segment fatty acids and light-damage susceptibility in P23H rats.

Authors:  Ina Rea Bicknell; Ruth Darrow; Linda Barsalou; Steven J Fliesler; Daniel T Organisciak
Journal:  Mol Vis       Date:  2002-09-05       Impact factor: 2.367

8.  Establishment of the mouse as a model animal for the study of diabetic cataracts.

Authors:  K R Hegde; M G Henein; S D Varma
Journal:  Ophthalmic Res       Date:  2003 Jan-Feb       Impact factor: 2.892

9.  Establishment of mouse as an animal model for study of diabetic cataracts: biochemical studies.

Authors:  K R Hegde; M G Henein; S D Varma
Journal:  Diabetes Obes Metab       Date:  2003-03       Impact factor: 6.577

10.  Glycation (non-enzymic glycosylation) inactivates glutathione reductase.

Authors:  R Blakytny; J J Harding
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

View more
  7 in total

1.  High sugar-induced repression of antioxidant and anti-apoptotic genes in lens: reversal by pyruvate.

Authors:  Shambhu D Varma; Krish Chandrasekaran
Journal:  Mol Cell Biochem       Date:  2015-02-25       Impact factor: 3.396

2.  Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy.

Authors:  Michal Laniado Schwartzman; Pavel Iserovich; Katherine Gotlinger; Lars Bellner; Michael W Dunn; Mauro Sartore; Maria Grazia Pertile; Andrea Leonardi; Sonal Sathe; Ann Beaton; Lynn Trieu; Robert Sack
Journal:  Diabetes       Date:  2010-04-27       Impact factor: 9.461

3.  The peroxisome proliferator-activated receptor-β/δ antagonist GSK0660 mitigates retinal cell inflammation and leukostasis.

Authors:  Megan E Capozzi; Sara R Savage; Gary W McCollum; Sandra S Hammer; Carla J Ramos; Rong Yang; Colin A Bretz; John S Penn
Journal:  Exp Eye Res       Date:  2019-11-20       Impact factor: 3.467

4.  Cytochrome P450-epoxygenated fatty acids inhibit Müller glial inflammation.

Authors:  Cayla D Ontko; Megan E Capozzi; Minjae J Kim; Gary W McCollum; John S Penn
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

5.  Effect of cytokine-induced alterations in extracellular matrix composition on diabetic retinopathy-relevant endothelial cell behaviors.

Authors:  Meredith J Giblin; Cayla D Ontko; John S Penn
Journal:  Sci Rep       Date:  2022-07-28       Impact factor: 4.996

6.  Remodeling of retinal Fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4.

Authors:  Maria Tikhonenko; Todd A Lydic; Yun Wang; Weiqin Chen; Madalina Opreanu; Andrew Sochacki; Kelly M McSorley; Rebecca L Renis; Timothy Kern; Donald B Jump; Gavin E Reid; Julia V Busik
Journal:  Diabetes       Date:  2009-10-29       Impact factor: 9.461

7.  Efficient Enrichment of Retinal DHA with Dietary Lysophosphatidylcholine-DHA: Potential Application for Retinopathies.

Authors:  Dhavamani Sugasini; Poorna C R Yalagala; Papasani V Subbaiah
Journal:  Nutrients       Date:  2020-10-12       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.